CD3+ graft cell count influence on chronic GVHD in haploidentical allogeneic transplantation using post-transplant cyclophosphamide
Published 2018 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
CD3+ graft cell count influence on chronic GVHD in haploidentical allogeneic transplantation using post-transplant cyclophosphamide
Authors
Keywords
-
Journal
BONE MARROW TRANSPLANTATION
Volume -, Issue -, Pages -
Publisher
Springer Nature
Online
2018-04-23
DOI
10.1038/s41409-018-0183-8
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Grade II Acute Graft-versus-Host Disease and Higher Nucleated Cell Graft Dose Improve Progression-Free Survival after HLA-Haploidentical Transplant with Post-Transplant Cyclophosphamide
- (2018) Shannon R. McCurdy et al. BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION
- Bone marrow versus mobilized peripheral blood stem cells in haploidentical transplants using posttransplantation cyclophosphamide
- (2018) Annalisa Ruggeri et al. CANCER
- Mobilized Peripheral Blood Stem Cells Versus Unstimulated Bone Marrow As a Graft Source for T-Cell–Replete Haploidentical Donor Transplantation Using Post-Transplant Cyclophosphamide
- (2017) Asad Bashey et al. JOURNAL OF CLINICAL ONCOLOGY
- Post-transplant cyclophosphamide, a promising anti-graft versus host disease prophylaxis: where do we stand?
- (2017) Alberto Mussetti et al. Expert Review of Hematology
- Infused total nucleated cell dose is a better predictor of transplant outcomes than CD34 + cell number in reduced-intensity mobilized peripheral blood allogeneic hematopoietic cell transplantation
- (2016) Paul S. Martin et al. HAEMATOLOGICA
- Comparable composite endpoints after HLA-matched and HLA-haploidentical transplantation with post-transplantation cyclophosphamide
- (2016) Shannon R. McCurdy et al. HAEMATOLOGICA
- Pre-transplant donor CD4− invariant NKT cell expansion capacity predicts the occurrence of acute graft-versus-host disease
- (2016) M-T Rubio et al. LEUKEMIA
- Comparable composite endpoints after HLA-matched and HLA-haploidentical transplantation with post-transplantation cyclophosphamide
- (2016) Shannon R. McCurdy et al. HAEMATOLOGICA
- Infused total nucleated cell dose is a better predictor of transplant outcomes than CD34 + cell number in reduced-intensity mobilized peripheral blood allogeneic hematopoietic cell transplantation
- (2016) Paul S. Martin et al. HAEMATOLOGICA
- Post-transplantation Cyclophosphamide and Sirolimus after Haploidentical Hematopoietic Stem Cell Transplantation Using a Treosulfan-based Myeloablative Conditioning and Peripheral Blood Stem Cells
- (2015) Nicoletta Cieri et al. BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION
- Risk-stratified outcomes of nonmyeloablative HLA-haploidentical BMT with high-dose posttransplantation cyclophosphamide
- (2015) S. R. McCurdy et al. BLOOD
- Haploidentical transplant with posttransplant cyclophosphamide vs matched unrelated donor transplant for acute myeloid leukemia
- (2015) S. O. Ciurea et al. BLOOD
- Composite end point of graft-versus-host disease-free, relapse-free survival after allogeneic hematopoietic cell transplantation
- (2015) S. G. Holtan et al. BLOOD
- Reduced-intensity transplantation for lymphomas using haploidentical related donors vs HLA-matched unrelated donors
- (2015) A. S. Kanate et al. BLOOD
- High Graft CD8 Cell Dose Predicts Improved Survival and Enables Better Donor Selection in Allogeneic Stem-Cell Transplantation With Reduced-Intensity Conditioning
- (2015) Ran Reshef et al. JOURNAL OF CLINICAL ONCOLOGY
- Peripheral Blood Progenitor Cell Mobilization for Autologous and Allogeneic Hematopoietic Cell Transplantation: Guidelines from the American Society for Blood and Marrow Transplantation
- (2014) Hien K. Duong et al. BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION
- Low CD34 Dose Is Associated with Poor Survival after Reduced-Intensity Conditioning Allogeneic Transplantation for Acute Myeloid Leukemia and Myelodysplastic Syndrome
- (2014) Johan Törlén et al. BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION
- Who is the best donor for a related HLA haplotype-mismatched transplant?
- (2014) Y. Wang et al. BLOOD
- Improved Survival After Transplantation of More Donor Plasmacytoid Dendritic or Naïve T Cells From Unrelated-Donor Marrow Grafts: Results From BMTCTN 0201
- (2014) Edmund K. Waller et al. JOURNAL OF CLINICAL ONCOLOGY
- Suggestions on the use of statistical methodologies in studies of the European Group for Blood and Marrow Transplantation
- (2013) Simona Iacobelli et al. BONE MARROW TRANSPLANTATION
- Unmanipulated Haploidentical Bone Marrow Transplantation and Posttransplantation Cyclophosphamide for Hematologic Malignancies after Myeloablative Conditioning
- (2012) Anna Maria Raiola et al. BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION
- A disease risk index for patients undergoing allogeneic stem cell transplantation
- (2012) P. Armand et al. BLOOD
- Defining the Intensity of Conditioning Regimens: Working Definitions
- (2009) Andrea Bacigalupo et al. BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION
- Nonmyeloablative HLA-Haploidentical Bone Marrow Transplantation with High-Dose Posttransplantation Cyclophosphamide: Effect of HLA Disparity on Outcome
- (2009) Yvette L. Kasamon et al. BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION
- Donor, recipient, and transplant characteristics as risk factors after unrelated donor PBSC transplantation: beneficial effects of higher CD34+ cell dose
- (2009) M. A. Pulsipher et al. BLOOD
- HLA-Haploidentical Bone Marrow Transplantation for Hematologic Malignancies Using Nonmyeloablative Conditioning and High-Dose, Posttransplantation Cyclophosphamide
- (2008) Leo Luznik et al. BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION
Add your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload NowCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now